Patent: 10,577,406
✉ Email this page to a colleague
Summary for Patent: 10,577,406
Title: | FKBP-L polypeptides and uses in angiogenesis-mediated disorders |
Abstract: | Disclosed are methods and compositions that employ FKBP-L polypeptides for modulating angiogenesis and/or tumor metastasis. The FKBP-L polypeptides may be used for the treatment of disorders mediated by angiogenesis such as cancer. |
Inventor(s): | Robson; Tracy (Northern Ireland, GB), Valentine; Andrea (Craigavon, GB), O\'Rourke; Martin Gerard (Craigavon, GB), Hirst; David (Northern Ireland, GB) |
Assignee: | ALMAC DISCOVERY LIMITED (GB) |
Application Number: | 15/169,460 |
Patent Claims: | see list of patent claims |
Details for Patent 10,577,406
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2026-06-09 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2026-06-09 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2026-06-09 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2026-06-09 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |